These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 6282762

  • 1. Monoclonal antibodies to Epstein-Barr virus-induced, transformation-associated cell surface antigens: binding patterns and effect upon virus-specific T-cell cytotoxicity.
    Rowe M, Hildreth JE, Rickinson AB, Epstein MA.
    Int J Cancer; 1982 Apr 15; 29(4):373-81. PubMed ID: 6282762
    [Abstract] [Full Text] [Related]

  • 2. Recognition of autologous lymphoblastoid cells by cloned human T cells: inhibition of cytotoxicity by anti-HLA antibody but not by antibody to Epstein-Barr virus induced cell surface antigen.
    Hank JA, Sondel PM.
    Hum Immunol; 1984 Apr 15; 9(4):211-9. PubMed ID: 6201468
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. HLA antigen-related restriction of T lymphocyte cytotoxicity to Epstein-Barr virus.
    Misko IS, Moss DJ, Pope JH.
    Proc Natl Acad Sci U S A; 1980 Jul 15; 77(7):4247-50. PubMed ID: 6254017
    [Abstract] [Full Text] [Related]

  • 10. Restricted expression of EBV latent genes and T-lymphocyte-detected membrane antigen in Burkitt's lymphoma cells.
    Rowe DT, Rowe M, Evan GI, Wallace LE, Farrell PJ, Rickinson AB.
    EMBO J; 1986 Oct 15; 5(10):2599-607. PubMed ID: 3023050
    [Abstract] [Full Text] [Related]

  • 11. Exclusive expression of Epstein-Barr virus nuclear antigen 1 in Burkitt lymphoma arises from a third promoter, distinct from the promoters used in latently infected lymphocytes.
    Schaefer BC, Woisetschlaeger M, Strominger JL, Speck SH.
    Proc Natl Acad Sci U S A; 1991 Aug 01; 88(15):6550-4. PubMed ID: 1713681
    [Abstract] [Full Text] [Related]

  • 12. Paired Epstein-Barr virus-carrying lymphoma and lymphoblastoid cell lines from Burkitt's lymphoma patients: comparative sensitivity to non-specific and to allo-specific cytotoxic responses in vitro.
    Rooney CM, Rickinson AB, Moss DJ, Lenoir GM, Epstein MA.
    Int J Cancer; 1984 Sep 15; 34(3):339-48. PubMed ID: 6090321
    [Abstract] [Full Text] [Related]

  • 13. Antigenic differences between the membrane antigen polypeptides determined by different EB virus isolates.
    Franklin SM, North JR, Morgan AJ, Epstein MA.
    J Gen Virol; 1981 Apr 15; 53(Pt 2):371-6. PubMed ID: 6167667
    [Abstract] [Full Text] [Related]

  • 14. Monoclonal antibody against a Burkitt lymphoma-associated antigen.
    Wiels J, Fellous M, Tursz T.
    Proc Natl Acad Sci U S A; 1981 Oct 15; 78(10):6485-8. PubMed ID: 7031655
    [Abstract] [Full Text] [Related]

  • 15. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.
    Rowe M, Khanna R, Jacob CA, Argaet V, Kelly A, Powis S, Belich M, Croom-Carter D, Lee S, Burrows SR.
    Eur J Immunol; 1995 May 15; 25(5):1374-84. PubMed ID: 7774641
    [Abstract] [Full Text] [Related]

  • 16. Class I major histocompatibility complex-restricted cytotoxic T lymphocytes specific for Epstein-Barr virus (EBV)-transformed B lymphoblastoid cell lines against which they were raised.
    Hill AB, Lee SP, Haurum JS, Murray N, Yao QY, Rowe M, Signoret N, Rickinson AB, McMichael AJ.
    J Exp Med; 1995 Jun 01; 181(6):2221-8. PubMed ID: 7539044
    [Abstract] [Full Text] [Related]

  • 17. Analysis of viral gene expression and genome persistence in CD23-positive and -negative subpopulations of Epstein-Barr-virus-infected BL2 cells.
    Doyle MG, Crawford DH.
    Intervirology; 1994 Jun 01; 37(5):236-44. PubMed ID: 7698878
    [Abstract] [Full Text] [Related]

  • 18. Observations on the EB virus envelope and virus-determined membrane antigen (MA) polypeptides.
    North JR, Morgan AJ, Epstein MA.
    Int J Cancer; 1980 Aug 01; 26(2):231-40. PubMed ID: 6162806
    [Abstract] [Full Text] [Related]

  • 19. Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line.
    Gregory CD, Rowe M, Rickinson AB.
    J Gen Virol; 1990 Jul 01; 71 ( Pt 7)():1481-95. PubMed ID: 2165133
    [Abstract] [Full Text] [Related]

  • 20. Cytotoxic T cell recognition of Epstein-Barr virus-infected B cells. I. Specificity and HLA restriction of effector cells reactivated in vitro.
    Moss DJ, Wallace LE, Rickinson AB, Epstein MA.
    Eur J Immunol; 1981 Sep 01; 11(9):686-93. PubMed ID: 6170517
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.